- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- Altana/Nycomed Encinitas, California, United States
- Altana/Nycomed Los Angeles, California, United States
- Altana/Nycomed Mission Viejo, California, United States
- Altana/Nycomed San Diego, California, United States
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,736 public trials
631 recruiting studies
Hypersensitivity, Immediate trial results
NCT00389025
- Conditions
- Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
- Locations
-
- Padova Site Padova, Italy
Completed
GSK2190915 Neutrophilic Asthma Study
NCT01471665
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Glasgow, Lanarkshire, United Kingdom
NCT01079000
- Conditions
- Acute Asthma, Asthma, Bronchial Diseases, +12 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada
- University of Alberta Edmonton, Alberta, Canada
NCT02966938
- Conditions
- Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +6 more
- Locations
-
Not specified
Completed
Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma
NCT00482248
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
NCT00785083
- Conditions
- Asthma, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +12 more
- Locations
-
- Novartis Investigator Site Manchester, United Kingdom
NCT01804400
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- Novartis Investigative Site Hanover, Germany
NCT00925730
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Novartis Investigative Site Bonn, Germany
- Novartis Investigative Site Frankfurt am Main, Germany
NCT00784732
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Novartis Investigator Site Toronto, Canada